PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Tezacaftor with ivacaftor - Cystic fibrosis
PAD Profile : Tezacaftor with ivacaftor - Cystic fibrosis Important
Brand Names Include :
Symkevi
Important Information :
NHSE Specialist Commissioned Services only
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Aztreonam
- Colistimethate sodium
- Dornase alfa
- Ivacaftor
- Tobramycin
- Levofloxacin
- Amikacin
- Amikacin liposomal
- Ciprofloxacin
- Ciprofloxacin liposomal
- Lumacaftor with ivacaftor
- Mannitol
- Antipseudomonas aeruginosa IgY
- Ivacaftor with tezacaftor and elexacaftor
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 June 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care
Associated BNF Codes
03. Respiratory System
03.07.00. Mucolytics